Brought to you by:
FDA approves LimFlow system for ‘no-option’ CLTI patients
The Food and Drug Administration (FDA) today announced approval of LimFlow therapy—a novel and minimally invasive procedure designed to bypass blockages in arteries of the legs and restore blood flow for many thousands of people suffering from chronic limb-threatening ischemia…
MVSS 2023: Aulivola takes over Midwestern Vascular reins
Bernadette Aulivola, MD, the division director of vascular surgery and endovascular therapy at Loyola University in Maywood, Illinois, took over as president of the Midwestern Vascular Surgical Society (MVSS) at the conclusion of the MVSS annual business meeting held in…
EVS 2023: Ozsvath assumes Eastern Vascular presidency
Kathleen Ozsvath, MD, a vascular surgeon at St. Peters Health Partners in Albany, New York, took over as president of the Eastern Vascular Society (EVS) during the 37th EVS annual meeting that took place in Washington, D.C. from Sept. 7–9.…
FDA clears AAA-SHAPE trial for IDE approval
Shape Memory Medical recently announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin a prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the Impede-FX RapidFill device to…
Multi-society guidelines on varicose vein management published
The Society for Vascular Surgery (SVS), American Venous Forum (AVF), and American Vein and Lymphatic Society (AVLS) have released the second and final part of new guidelines for the management of varicose veins of the lower extremities. The recommendations, which…
Vascular Nurses Week shines spotlight on vital role in patient care and innovation
In a world in which both medical breakthroughs and technological advancements seem to dominate the healthcare landscape, it’s easy to overlook the unsung heroes who work tirelessly to ensure that patients receive the specialized care they need. Vascular Nurses Week—Sept.…
SVS urges members to take part in compensation survey—and bolster results
Organizers behind an SVS-commissioned financial compensation survey are calling on more members to fill out the short list of questions so that they can break a key 20% response-rate target and begin to publish data gleaned from participants. Any member…
CMS: Proposed reduced conversion factor would cut vascular surgeon reimbursements
The Centers for Medicare & Medicaid Services (CMS) in mid-July released two payment-related proposed rules—the highly-anticipated calendar year (CY) 2024 Medicare Physician Fee Schedule Proposed Rule (MPFS) and the Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center…
Submit ideas for VAM 2024 educational sessions
Organizers of VAM 2024 want members to consider what the modern-day vascular surgeon needs to know for optimal patient care and professional success. What’s the latest in the venous disease space? What are helpful tips and tricks in open surgery…
SVS members rally to respond to CMS carotid stenting coverage proposal
Nearly one-third of the public comments submitted to the Centers for Medicare & Medicaid Services (CMS) on a controversial proposed coverage decision affecting carotid stenting were from SVS members. “We could not have been more pleased with our members’ response…